1007 related articles for article (PubMed ID: 8980224)
1. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
Suri C; Jones PF; Patan S; Bartunkova S; Maisonpierre PC; Davis S; Sato TN; Yancopoulos GD
Cell; 1996 Dec; 87(7):1171-80. PubMed ID: 8980224
[TBL] [Abstract][Full Text] [Related]
2. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.
Davis S; Aldrich TH; Jones PF; Acheson A; Compton DL; Jain V; Ryan TE; Bruno J; Radziejewski C; Maisonpierre PC; Yancopoulos GD
Cell; 1996 Dec; 87(7):1161-9. PubMed ID: 8980223
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
[TBL] [Abstract][Full Text] [Related]
4. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
5. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth.
Patan S
Microvasc Res; 1998 Jul; 56(1):1-21. PubMed ID: 9683559
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
7. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.
Yu Y; Varughese J; Brown LF; Mulliken JB; Bischoff J
Am J Pathol; 2001 Dec; 159(6):2271-80. PubMed ID: 11733376
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.
Witzenbichler B; Maisonpierre PC; Jones P; Yancopoulos GD; Isner JM
J Biol Chem; 1998 Jul; 273(29):18514-21. PubMed ID: 9660821
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel.
Peters KG
Circ Res; 1998 Aug; 83(3):342-3. PubMed ID: 9710128
[No Abstract] [Full Text] [Related]
10. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
11. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in embryonic development--a review.
Breier G
Placenta; 2000; 21 Suppl A():S11-5. PubMed ID: 10831116
[TBL] [Abstract][Full Text] [Related]
13. Signaling vascular morphogenesis and maintenance.
Hanahan D
Science; 1997 Jul; 277(5322):48-50. PubMed ID: 9229772
[No Abstract] [Full Text] [Related]
14. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
[TBL] [Abstract][Full Text] [Related]
15. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
16. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.
Satchell SC; Harper SJ; Tooke JE; Kerjaschki D; Saleem MA; Mathieson PW
J Am Soc Nephrol; 2002 Feb; 13(2):544-550. PubMed ID: 11805186
[TBL] [Abstract][Full Text] [Related]
17. Expression and hypoxic regulation of angiopoietins in human astrocytomas.
Ding H; Roncari L; Wu X; Lau N; Shannon P; Nagy A; Guha A
Neuro Oncol; 2001 Jan; 3(1):1-10. PubMed ID: 11305411
[TBL] [Abstract][Full Text] [Related]
18. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.
Gale NW; Yancopoulos GD
Genes Dev; 1999 May; 13(9):1055-66. PubMed ID: 10323857
[No Abstract] [Full Text] [Related]
19. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.
Patan S
J Neurooncol; 2000; 50(1-2):1-15. PubMed ID: 11245270
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic therapy targeting factors that enhance endothelial cell survival.
Liu W; Reinmuth N; Stoeltzing O; Parikh AA; Fan F; Ahmad SA; Jung YD; Ellis LM
Semin Oncol; 2002 Jun; 29(3 Suppl 11):96-103. PubMed ID: 12138403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
